Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
19,479,257
-
Share change
-
+1,602,211
-
Total reported value
-
$186,998,333
-
Price per share
-
$9.60
-
Number of holders
-
94
-
Value change
-
+$18,103,190
-
Number of buys
-
64
-
Number of sells
-
32
Institutional Holders of EIGER BIOPHARMACEUTICALS INC - COM (EIGR) as of Q2 2020
As of 30 Jun 2020,
EIGER BIOPHARMACEUTICALS INC - COM (EIGR) was held by
94 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,479,257 shares.
The largest 10 holders included
683 Capital Management, LLC, BlackRock Inc., Vivo Capital, LLC, VANGUARD GROUP INC, MANGROVE PARTNERS, CITADEL ADVISORS LLC, INTERWEST VENTURE MANAGEMENT CO, Cormorant Asset Management, LP, Soleus Capital Management, L.P., and Knoll Capital Management, LP.
This page lists
94
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.